ÂÜÀòÂÒÂ×

Arvin Gouw is currently the Chief Executive Officer at Bacchus Therapeutics and Vice President of Research & Development at Rare Genomics Institute. With a background in cancer research, nanotechnology, and neurogenesis, Arvin has extensive experience in the field. Arvin has also pursued various degrees in oncology, business, law, philosophy, and theology, showcasing their diverse academic interests. Through their participation in programs like SPARK and their work at institutions like Stanford University School of Medicine, Arvin has demonstrated a commitment to advancing research discoveries in rare diseases and cancer.